1
|
Sharma R: Breast cancer incidence,
mortality and mortality-to-incidence ratio (MIR) are associated
with human development, 1990-2016: Evidence from global burden of
disease study 2016. Breast Cancer. 26:428–445. 2019.PubMed/NCBI View Article : Google Scholar
|
2
|
Greenberg PA, Hortobagyi GN, Smith TL,
Ziegler LD, Frye DK and Buzdar AU: Long-term follow-up of patients
with complete remission following combination chemotherapy for
metastatic breast cancer. J Clin Oncol. 14:2197–2205.
1996.PubMed/NCBI View Article : Google Scholar
|
3
|
Clarke M, Collins R, Darby S, Davies C,
Elphinstone P, Evans V, Godwin J, Gray R, Hicks C, James S, et al:
Effects of radiotherapy and of differences in the extent of surgery
for early breast cancer on local recurrence and 15-year survival:
An overview of the randomised trials. Lancet. 366:2087–2106.
2005.PubMed/NCBI View Article : Google Scholar
|
4
|
Eggemann H, Ignatov T, Beni A, Costa SD
and Ignatov A: Ultrasonography-guided breast-conserving surgery is
superior to palpation-guided surgery for palpable breast cancer.
Clin Breast Cancer. 14:40–45. 2014.PubMed/NCBI View Article : Google Scholar
|
5
|
Koh J, Park AY, Ko KH and Jung HK: Can
enhancement types on preoperative MRI reflect prognostic factors
and surgical outcomes in invasive breast cancer? Eur Radiol.
29:7000–7008. 2019.PubMed/NCBI View Article : Google Scholar
|
6
|
Balleyguier C, Dunant A, Ceugnart L,
Kandel M, Chauvet MP, Chérel P, Mazouni C, Henrot P, Rauch P,
Chopier J, et al: Preoperative breast magnetic resonance imaging in
women with local ductal carcinoma in situ to optimize surgical
outcomes: Results from the randomized phase III trial IRCIS. J Clin
Oncol. 37:885–892. 2019.PubMed/NCBI View Article : Google Scholar
|
7
|
Houssami N, Turner RM and Morrow M:
Meta-analysis of pre-operative magnetic resonance imaging (MRI) and
surgical treatment for breast cancer. Breast Cancer Res Treat.
165:273–283. 2017.PubMed/NCBI View Article : Google Scholar
|
8
|
Houssami N, Turner R and Morrow M:
Preoperative magnetic resonance imaging in breast cancer:
Meta-analysis of surgical outcomes. Ann Surg. 257:249–255.
2013.PubMed/NCBI View Article : Google Scholar
|
9
|
Turnbull L, Brown S, Harvey I, Olivier C,
Drew P, Napp V, Hanby A and Brown J: Comparative effectiveness of
MRI in breast cancer (COMICE) trial: A randomised controlled trial.
Lancet. 375:563–571. 2010.PubMed/NCBI View Article : Google Scholar
|
10
|
Yamashiro N, Tozaki M, Ogawa T, Kawano N,
Suzuki T, Ozaki S, Sakamoto N, Abe S and Fukuma E: Preoperative MRI
marking technique for the planning of breast-conserving surgery.
Breast Cancer. 16:223–228. 2009.PubMed/NCBI View Article : Google Scholar
|
11
|
Sakakibara M, Nagashima T, Sangai T,
Nakamura R, Fujimoto H, Arai M, Kazama T, Hashimoto H, Nakatani Y
and Miyazaki M: Breast-conserving surgery using projection and
reproduction techniques of surgical-position breast MRI in patients
with ductal carcinoma in situ of the breast. J Am Coll Surg.
207:62–68. 2008.PubMed/NCBI View Article : Google Scholar
|
12
|
Chen K, Zhu L, Chen L, Li Q, Li S, Qiu N,
Yang Y, Su F and Song E: Circumferential shaving of the cavity in
breast-conserving surgery: A randomized controlled trial. Ann Surg
Oncol. 26:4256–4263. 2019.PubMed/NCBI View Article : Google Scholar
|
13
|
Langhans L, Tvedskov TF, Klausen TL,
Jensen MB, Talman ML, Vejborg I, Benian C, Roslind A, Hermansen J,
Oturai PS, et al: Radioactive seed localization or wire-guided
localization of nonpalpable invasive and in situ breast cancer: A
randomized, multicenter, open-label trial. Ann Surg. 266:29–35.
2017.PubMed/NCBI View Article : Google Scholar
|
14
|
McGhan LJ, Wasif N, Gray RJ, Giurescu ME,
Pizzitola VJ, Lorans R, Ocal IT, Stucky CC and Pockaj BA: Use of
preoperative magnetic resonance imaging for invasive lobular
cancer: Good, better, but maybe not the best? Ann Surg Oncol. 17
(Suppl 3):S255–S262. 2010.PubMed/NCBI View Article : Google Scholar
|
15
|
Peters NH, van Esser S, van den Bosch MA,
Storm RK, Plaisier PW, van Dalen T, Diepstraten SC, Weits T,
Westenend PJ, Stapper G, et al: Preoperative MRI and surgical
management in patients with nonpalpable breast cancer: The
MONET-randomised controlled trial. Eur J Cancer. 47:879–886.
2011.PubMed/NCBI View Article : Google Scholar
|
16
|
Lai HW, Huang RH, Wu YT, Chen CJ, Chen ST,
Lin YJ, Chen DR, Lee CW, Wu HK, Lin HY and Kuo SJ:
Clinicopathologic factors related to surgical margin involvement,
reoperation, and residual cancer in primary operable breast
cancer-an analysis of 2050 patients. Eur J Surg Oncol.
44:1725–1735. 2018.PubMed/NCBI View Article : Google Scholar
|
17
|
Chandwani S, George PA, Azu M, Bandera EV,
Ambrosone CB, Rhoads GG and Demissie K: Role of preoperative
magnetic resonance imaging in the surgical management of
early-stage breast cancer. Ann Surg Oncol. 21:3473–3480.
2014.PubMed/NCBI View Article : Google Scholar
|
18
|
Bae SJ, Ahn SG, Yoon CI, Yang BS, Lee HW,
Son EJ and Jeong J: Measuring tumor extent based on subtypes using
magnetic resonance imaging: Radiologic-pathologic discordance and
high positive margin rates in breast cancer. J Breast Cancer.
22:453–463. 2019.PubMed/NCBI View Article : Google Scholar
|
19
|
Petrillo A, Fusco R, Petrillo M, Triunfo
F, Filice S, Vallone P, Setola SV, Rubulotta M, Di Bonito M,
Rinaldo M, et al: Added value of breast MRI for preoperative
diagnosis of ductal carcinoma in situ: Diagnostic performance on
362 patients. Clin Breast Cancer. 17:e127–e134. 2017.PubMed/NCBI View Article : Google Scholar
|